9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Resonance energy transfer sensitises and monitors in situ switching of LOV2-based optogenetic actuators

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Engineered light-dependent switches provide uniquely powerful opportunities to investigate and control cell regulatory mechanisms. Existing tools offer high spatiotemporal resolution, reversibility and repeatability. Cellular optogenetics applications remain limited with diffusible targets as the response of the actuator is difficult to independently validate. Blue light levels commonly needed for actuation can be cytotoxic, precluding long-term experiments. We describe a simple approach overcoming these obstacles. Resonance energy transfer can be used to constitutively or dynamically modulate actuation sensitivity. This simultaneously offers on-line monitoring of light-dependent switching and precise quantification of activation-relaxation properties in intact living cells. Applying this approach to different LOV2-based switches reveals that flanking sequences can lead to relaxation times up to 11-fold faster than anticipated. In situ–measured parameter values guide the design of target-inhibiting actuation trains with minimal blue-light exposure, and context-based optimisation can increase sensitivity and experimental throughput a further 10-fold without loss of temporal precision.

          Abstract

          Cellular optogenetics applications are limited by difficulties in quantification and blue light toxicity. Here the authors design LOV2-based switches that use resonance energy transfer to overcome these concerns.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: not found

          Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets

          Phase transitions driven by intrinsically disordered protein regions (IDRs) have emerged as a ubiquitous mechanism for assembling liquid-like RNA/protein (RNP) bodies and other membrane-less organelles. However, a lack of tools to control intracellular phase transitions limits our ability to understand their role in cell physiology and disease. Here, we introduce an optogenetic platform that uses light to activate IDR-mediated phase transitions in living cells. We use this "optoDroplet" system to study condensed phases driven by the IDRs of various RNP body proteins, including FUS, DDX4, and HNRNPA1. Above a concentration threshold, these constructs undergo light-activated phase separation, forming spatiotemporally definable liquid optoDroplets. FUS optoDroplet assembly is fully reversible even after multiple activation cycles. However, cells driven deep within the phase boundary form solid-like gels that undergo aging into irreversible aggregates. This system can thus elucidate not only physiological phase transitions but also their link to pathological aggregates.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            High-sensitivity measurements of multiple kinase activities in live single cells.

            Increasing evidence has shown that population dynamics are qualitatively different from single-cell behaviors. Reporters to probe dynamic, single-cell behaviors are desirable yet relatively scarce. Here, we describe an easy-to-implement and generalizable technology to generate reporters of kinase activity for individual cells. Our technology converts phosphorylation into a nucleocytoplasmic shuttling event that can be measured by epifluorescence microscopy. Our reporters reproduce kinase activity for multiple types of kinases and allow for calculation of active kinase concentrations via a mathematical model. Using this technology, we made several experimental observations that had previously been technicallyunfeasible, including stimulus-dependent patterns of c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-κB) activation. We also measured JNK, p38, and ERK activities simultaneously, finding that p38 regulates the peak number, but not the intensity, of ERK fluctuations. Our approach opens the possibility of analyzing a wide range of kinase-mediated processes in individual cells. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A genetically-encoded photoactivatable Rac controls the motility of living cells

              The precise spatio-temporal dynamics of protein activity are often critical in determining cell behaviour, yet for most proteins they remain poorly understood; it remains difficult to manipulate protein activity at precise times and places within living cells. Protein activity has been controlled by light, through protein derivatization with photocleavable moieties1 or using photoreactive small molecule ligands2. However, this requires use of toxic UV wavelengths, activation is irreversible, and/or cell loading is accomplished via disruption of the cell membrane (i.e. through microinjection). We have developed a new approach to produce genetically-encoded photo-activatable derivatives of Rac1, a key GTPase regulating actin cytoskeletal dynamics3,4. Rac1 mutants were fused to the photoreactive LOV (light oxygen voltage) domain from phototropin5,6, sterically blocking Rac1 interactions until irradiation unwound a helix linking LOV to Rac1. Photoactivatable Rac1 (PA-Rac1) could be reversibly and repeatedly activated using 458 or 473 nm light to generate precisely localized cell protrusions and ruffling. Localized Rac activation or inactivation was sufficient to produce cell motility and control the direction of cell movement. Myosin was involved in Rac control of directionality but not in Rac-induced protrusion, while PAK was required for Rac-induced protrusion. PA-Rac1 was used to elucidate Rac regulation of RhoA in cell motility. Rac and Rho coordinate cytoskeletal behaviours with seconds and submicron precision7,8. Their mutual regulation remains controversial9, with data indicating that Rac inhibits and/or activates Rho10,11. Rac was shown to inhibit RhoA in living cells, with inhibition modulated at protrusions and ruffles. A PA-Rac crystal structure and modelling revealed LOV-Rac interactions that will facilitate extension of this photoactivation approach to other proteins.
                Bookmark

                Author and article information

                Contributors
                michael.courtney@bioscience.fi
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                9 October 2020
                9 October 2020
                2020
                : 11
                : 5107
                Affiliations
                [1 ]GRID grid.1374.1, ISNI 0000 0001 2097 1371, Neuronal Signalling Lab, Turku Bioscience Centre, , University of Turku and Åbo Academy University, ; Biocity, Turku Finland
                [2 ]Turku Screening Unit, Biocity, Turku Finland
                [3 ]Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University, Frankfurt, Germany
                [4 ]GRID grid.5335.0, ISNI 0000000121885934, Present Address: Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, , University of Cambridge, ; Cambridge, UK
                [5 ]GRID grid.460296.f, Present Address: BLIRT S.A., ; Trzy Lipy 3/1.38, 80-172 Gdansk, Poland
                Author information
                http://orcid.org/0000-0002-8888-153X
                http://orcid.org/0000-0002-1909-7645
                http://orcid.org/0000-0003-1438-3850
                http://orcid.org/0000-0001-8693-3933
                Article
                18816
                10.1038/s41467-020-18816-8
                7547724
                33037199
                5e39093c-c5c2-4d33-86de-224b5160c5d0
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 25 February 2020
                : 8 September 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100004155, Magnus Ehrnroothin Säätiö (Magnus Ehrnrooth Foundation);
                Funded by: FundRef https://doi.org/10.13039/100000054, U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI);
                Award ID: R01CA200417
                Award ID: R01CA200417
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100002341, Academy of Finland (Suomen Akatemia);
                Award ID: 309736, 324581
                Award Recipient :
                Funded by: 7th Framework Programme Initial Training Networks FP7-PEOPLE-2013-ITN Project Number 608346 Project ‘Brain Imaging Return To Health’ r’Birth
                Funded by: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
                Funded by: FundRef https://doi.org/10.13039/501100010790, EC | Erasmus+;
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                optogenetics,protein design,synthetic biology
                Uncategorized
                optogenetics, protein design, synthetic biology

                Comments

                Comment on this article